Positive Early Results For Parkinson’s Treatment
Initial studies funded by the Michael J. Fox Foundation show Harbor BioSciences’ Triolex for Parkinson’s disease crosses the blood-brain barrier in mice.
Read MoreInitial studies funded by the Michael J. Fox Foundation show Harbor BioSciences’ Triolex for Parkinson’s disease crosses the blood-brain barrier in mice.
Read MoreAn interview with Clinical Laboratory ManagementAssociation President C. Anne Pontius.
Read MoreThermo Fisher Scientific Inc
Read MoreSpectronics CorpOlympus America IncRandox Pharma ServicesCoulbourn Instruments
Read More